» Articles » PMID: 32865671

Is Diabetes Mellitus a Risk Factor for COronaVIrus Disease 19 (COVID-19)?

Overview
Journal Acta Diabetol
Specialty Endocrinology
Date 2020 Sep 1
PMID 32865671
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

The COronaVirus DISease 19 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2). Older age and presence of comorbidities, including diabetes, were shown to be associated with a more severe course and a higher fatality rate. Studies from the most affected countries, including China, United States and Italy, seem to indicate that prevalence of diabetes among patients affected by COVID-19 is not higher than that observed in the general population, thus suggesting that diabetes is not a risk factor for SARS-CoV-2 infection. However, a large body of evidence demonstrate that diabetes is a risk factor for disease progression towards critical illness, development of acute respiratory distress syndrome, need for mechanical ventilation or admission to intensive care unit, and ultimately death. The mechanisms underlying the relationship between COVID-19 and diabetes remain to be elucidated. In particular, it is still unresolved whether is diabetes per se, especially if poorly controlled, or rather the various comorbidities/complications associated with it that predispose patients with COVID-19 to a worse prognosis. In fact, conditions that cluster with diabetes in the context of the metabolic syndrome, such as obesity and hypertension, or complicate chronic hyperglycemia, such as cardiovascular disease and chronic kidney disease, have also been associated with poor prognosis in these individuals and the available studies have not consistently shown that diabetes predict disease severity independently of them.

Citing Articles

The Association Between Diabetes and the Outcome of COVID-19 Infection in Bethlehem, Palestine: A Case-Control Study.

Abu-Helu R, Zeer M, Adwan G J Pathog. 2025; 2024:1051658.

PMID: 39995847 PMC: 11850064. DOI: 10.1155/2024/1051658.


Association Between COVID-19 and Diabetes Management Indices in Japanese Type 2 Diabetes Mellitus Patients: A Single-Center, Retrospective Study.

Furumachi K, Kagatsume T, Higuchi A, Kozaru M, Kumagai E, Hosohata K Infect Drug Resist. 2024; 17:3759-3767.

PMID: 39224903 PMC: 11368151. DOI: 10.2147/IDR.S475917.


Individual risk factors associated with SARS-CoV-2 infection during Alpha variant in high-income countries: a systematic review and meta-analysis.

Moniz M, Pereira S, Soares P, Aguiar P, Donato H, Leite A Front Public Health. 2024; 12:1367480.

PMID: 39139667 PMC: 11319152. DOI: 10.3389/fpubh.2024.1367480.


Covid-19 and Pre-Morbid Lifestyle-Related Risk Factors-A Review.

Monye I, Makinde M, Idris Ahmad Oseni T, Bamidele Adelowo A, Nyirenda S Health Serv Insights. 2023; 16:11786329231215049.

PMID: 38046558 PMC: 10691316. DOI: 10.1177/11786329231215049.


In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio, Predict COVID-19 Susceptibility and Survival in a Prospective....

Tobi M, Bluth M, Rossi N, Demian E, Talwar H, Tobi Y Int J Mol Sci. 2023; 24(8).

PMID: 37108697 PMC: 10145175. DOI: 10.3390/ijms24087536.


References
1.
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J . Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect. 2020; 81(2):e16-e25. PMC: 7177098. DOI: 10.1016/j.jinf.2020.04.021. View

2.
Drosten C, Gunther S, Preiser W, van der Werf S, Brodt H, Becker S . Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1967-76. DOI: 10.1056/NEJMoa030747. View

3.
Muniyappa R, Gubbi S . COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab. 2020; 318(5):E736-E741. PMC: 7191633. DOI: 10.1152/ajpendo.00124.2020. View

4.
Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X . Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7222577. DOI: 10.1136/bmjdrc-2020-001343. View

5.
Ji H, Zhao R, Matalon S, Matthay M . Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility. Physiol Rev. 2020; 100(3):1065-1075. PMC: 7191627. DOI: 10.1152/physrev.00013.2020. View